140 related articles for article (PubMed ID: 27834791)
1. Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes.
Bzymek KP; Avery KA; Ma Y; Horne DA; Williams JC
Acta Crystallogr F Struct Biol Commun; 2016 Nov; 72(Pt 11):820-830. PubMed ID: 27834791
[TBL] [Abstract][Full Text] [Related]
2. Meditope-Fab interaction: threading the hole.
Bzymek KP; Ma Y; Avery KN; Horne DA; Williams JC
Acta Crystallogr F Struct Biol Commun; 2017 Dec; 73(Pt 12):688-694. PubMed ID: 29199990
[TBL] [Abstract][Full Text] [Related]
3. Cyclization strategies of meditopes: affinity and diffraction studies of meditope-Fab complexes.
Bzymek KP; Ma Y; Avery KA; Horne DA; Williams JC
Acta Crystallogr F Struct Biol Commun; 2016 Jun; 72(Pt 6):434-42. PubMed ID: 27303895
[TBL] [Abstract][Full Text] [Related]
4. Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies.
Donaldson JM; Zer C; Avery KN; Bzymek KP; Horne DA; Williams JC
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17456-61. PubMed ID: 24101516
[TBL] [Abstract][Full Text] [Related]
5. Bacterial production and structure-functional validation of a recombinant antigen-binding fragment (Fab) of an anti-cancer therapeutic antibody targeting epidermal growth factor receptor.
Kim JH; Sim DW; Park D; Jung TG; Lee S; Oh T; Ha JR; Seok SH; Seo MD; Kang HC; Kim YP; Won HS
Appl Microbiol Biotechnol; 2016 Dec; 100(24):10521-10529. PubMed ID: 27470143
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
7. Structural Analysis of Der p 1-Antibody Complexes and Comparison with Complexes of Proteins or Peptides with Monoclonal Antibodies.
Osinski T; Pomés A; Majorek KA; Glesner J; Offermann LR; Vailes LD; Chapman MD; Minor W; Chruszcz M
J Immunol; 2015 Jul; 195(1):307-16. PubMed ID: 26026055
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of an anti-interleukin-2 monoclonal antibody Fab complexed with an antigenic nonapeptide.
Afonin PV; Fokin AV; Tsygannik IN; Mikhailova IY; Onoprienko LV; Mikhaleva II; Ivanov VT; Mareeva TY; Nesmeyanov VA; Li N; Pangborn WA; Duax WL; Pletnev VZ
Protein Sci; 2001 Aug; 10(8):1514-21. PubMed ID: 11468348
[TBL] [Abstract][Full Text] [Related]
9. High resolution structures of the 4-4-20 Fab-fluorescein complex in two solvent systems: effects of solvent on structure and antigen-binding affinity.
Herron JN; Terry AH; Johnston S; He XM; Guddat LW; Voss EW; Edmundson AB
Biophys J; 1994 Dec; 67(6):2167-83. PubMed ID: 7696460
[TBL] [Abstract][Full Text] [Related]
10. Engineering a high-affinity peptide binding site into the anti-CEA mAb M5A.
Zer C; Avery KN; Meyer K; Goodstein L; Bzymek KP; Singh G; Williams JC
Protein Eng Des Sel; 2017 Jun; 30(6):409-417. PubMed ID: 28431161
[TBL] [Abstract][Full Text] [Related]
11. Induced peptide conformations in different antibody complexes: molecular modeling of the three-dimensional structure of peptide-antibody complexes using NMR-derived distance restraints.
Scherf T; Hiller R; Naider F; Levitt M; Anglister J
Biochemistry; 1992 Aug; 31(30):6884-97. PubMed ID: 1379072
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
[TBL] [Abstract][Full Text] [Related]
13. Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition.
Scheerer P; Kramer A; Otte L; Seifert M; Wessner H; Scholz C; Krauss N; Schneider-Mergener J; Höhne W
J Mol Recognit; 2007; 20(4):263-74. PubMed ID: 17712773
[TBL] [Abstract][Full Text] [Related]
14. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface.
Muller YA; Chen Y; Christinger HW; Li B; Cunningham BC; Lowman HB; de Vos AM
Structure; 1998 Sep; 6(9):1153-67. PubMed ID: 9753694
[TBL] [Abstract][Full Text] [Related]
15. Dissection of binding interactions in the complex between the anti-lysozyme antibody HyHEL-63 and its antigen.
Li Y; Urrutia M; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2003 Jan; 42(1):11-22. PubMed ID: 12515535
[TBL] [Abstract][Full Text] [Related]
16. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
17. Detailed analysis of the free and bound conformations of an antibody. X-ray structures of Fab 17/9 and three different Fab-peptide complexes.
Schulze-Gahmen U; Rini JM; Wilson IA
J Mol Biol; 1993 Dec; 234(4):1098-118. PubMed ID: 8263915
[TBL] [Abstract][Full Text] [Related]
18. Mechanically interlocked functionalization of monoclonal antibodies.
Bzymek KP; Puckett JW; Zer C; Xie J; Ma Y; King JD; Goodstein LH; Avery KN; Colcher D; Singh G; Horne DA; Williams JC
Nat Commun; 2018 Apr; 9(1):1580. PubMed ID: 29679060
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.
Li S; Schmitz KR; Jeffrey PD; Wiltzius JJ; Kussie P; Ferguson KM
Cancer Cell; 2005 Apr; 7(4):301-11. PubMed ID: 15837620
[TBL] [Abstract][Full Text] [Related]
20. Anchoring a cationic ligand: the structure of the Fab fragment of the anti-morphine antibody 9B1 and its complex with morphine.
Pozharski E; Wilson MA; Hewagama A; Shanafelt AB; Petsko G; Ringe D
J Mol Biol; 2004 Mar; 337(3):691-7. PubMed ID: 15019787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
